Morningstar
•
Nov 05, 2026
Qiagen N.V.: Qiagen Earnings: Consumables Sales Boost Growth and Margin Expansion
Summary
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company’s sales are split almost evenly between life sciences and molecular diagnostics applications. Qiagen generates nearly 90% of its revenue from
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Bio-Rad Laboratories, Inc.
Nov 05, 2026
•
BIO
BRKR: Lowering target price to $59.00
Nov 04, 2026
•
BRKR
NBIX: Rating increased to a BUY
Nov 04, 2026
•
NBIX
WAT: Lowering target price to $506.00
Nov 04, 2026
•
WAT
QDEL: What does Argus have to say about QDEL?
Nov 04, 2026
•
QDEL
